Skip to main content

Advertisement

Log in

Pathophysiology and antioxidant status of patients with fibromyalgia

  • Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Fibromyalgia syndrome (FMS) is characterized by systemic pain of unknown etiology and is often accompanied by various psychological symptoms. Research on different parameters in fibromyalgia (FM) indicates that multifactors are involved in its pathophysiology; such as genetic factors, substance P, serotonin, hypothalamic pituitary adrenal axis (HPA), muscles metabolic dysfunction, reactive oxygen species (ROS) and reactive nitrogen species (RNS). Oxidative stress has also been implicated in the pathophysiology of FM; therefore, supplementation with antioxidants may be important in modulation of the effects of ROS in patients with FM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Goldenberg DL (1997) Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol 9:135–143. doi:10.1097/00002281-199703000-00010

    Article  CAS  PubMed  Google Scholar 

  2. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, Russell IJ, Yunus MB (1997) Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum 40:1571–1579. doi:10.1002/art.1780400905

    Article  CAS  PubMed  Google Scholar 

  3. Hudson JI, Goldenberg DL, Pope HG, Keck PE, Schlesinger L (1992) Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 92:363–367. doi:10.1016/0002-9343(92)90265-D

    Article  CAS  PubMed  Google Scholar 

  4. Houdenhove BV, Luyten P (2006) Stress depression and fibromyalgia. Acta Neurol Belg 149–156

  5. Olson J (2004) Mapping genes for fibromyalgia. NIAMS spotlight on research, fibromyalgia: summaries of research. National institute of arthritis and musculoskeletal and skin diseases

  6. Griep EN, Boersma JW, De Kloet ER (1993) Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 20:469–474

    CAS  PubMed  Google Scholar 

  7. Crofford LJ, Pillemer SR, Kalogeras KT (1994) Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 11:1583–1592. doi:10.1002/art.1780371105

    Article  Google Scholar 

  8. Ross R, Jones K, Eldredge D (2004) Clinical and biochemical features of atypical and melancholic depression subtypes in fibromyalgia patients. Program and abstracts of the American College of Rheumatology (ACR) 71st annual meeting

  9. Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA (1992) latelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 19:104–109

    CAS  PubMed  Google Scholar 

  10. Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC (1992) Plasma tryptophan and other amino acids in primary fibromyalgia. A controlled study. J Rheumatol 19:90–94

    CAS  PubMed  Google Scholar 

  11. Larson AA, Giovengo SL, Russell IJ, Michalek JE (2000) Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain 87:201–211. doi:10.1016/S0304-3959(00)00284-0

    Article  CAS  PubMed  Google Scholar 

  12. Vaeroy H, Helle R, Forre O (1998) Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia. New features for diagnosis. Pain 32:21–26. doi:10.1016/0304-3959(88)90019-X

    Article  Google Scholar 

  13. Rauch SL, Shin LM, Phelps EA (2006) Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research—past, present, and future. Biol Psychiatry 60:376–382. doi:10.1016/j.biopsych.2006.06.004

    Article  PubMed  Google Scholar 

  14. Harris RH, Sundgren PC, Pang Y (2007) Variation in glutamate and glutamine levels within the insula are associated with improvements in clinical and experimental pain in fibromyalgia. Program and abstracts of the American College of Rheumatology (ACR) 71st annual meeting. Boston, Massachusetts

    Google Scholar 

  15. Buskila D, Neumann L, Vaisberg G, Alkalay D, Wolfe F (1997) Increased rates of fibromyalgia following cervical spine injury. A controlled study of 161 cases of traumatic injury. Arthritis Rheum 40(3):446–452. doi:10.1002/art.1780400310

    Article  CAS  PubMed  Google Scholar 

  16. Jeschonneck M, Graohmann G, Hein G, Sprott H (2002) Abnormal microcirculation and temperature in skin above tender points in patients with fibromyalgia. Rheumatology 39:917–921. doi:10.1093/rheumatology/39.8.917

    Article  Google Scholar 

  17. Lund N, Bengtsson A, Thorborg P (1986) Muscle oxygen tissue pressure in primary fibromyalgia. Scand J Rheumatol 15:165–173. doi:10.3109/03009748609102084

    Article  CAS  PubMed  Google Scholar 

  18. Titova DC, Oeser A, Chung CP, et al (2007) Oxidative stress in fibromyalgia: relationship to symptoms. Program and abstracts of the American college of Rheumatology (ACR) 71st annual meeting

  19. Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O (2001) Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 64:43–51. doi:10.1016/S0165-0327(00)00199-3

    Article  CAS  PubMed  Google Scholar 

  20. Eisinger J, Gandolfo C, Zakarian H, Ayavou T (1997) Reactive oxygen species, antioxidant status and fibromyalgia. J Musculoskeletal Pain 5:5–15. doi:10.1300/J094v05n04_02

    Article  Google Scholar 

  21. Bagis S, Tamer L, Sahin G, Bilgin R, Guler H, Ercan B, Erdogan C (2005) Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder. Rheumatol Int 25:188–190. doi:10.1007/s00296-003-0427-8

    Article  CAS  PubMed  Google Scholar 

  22. Ozgocmen S, Ozyurt H, Sogut S, Akyol O, Ardicoglu O, Yidizhan H (2005) Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int

  23. Sendur OF, Turan Y, Tastaban E, Yenisey C, Serter M (2008) Serum antioxidants and nitric oxide levels in fibromyalgia: a controlled study. Rheumatol Int

  24. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND (2004) Glutathione metabolism and its implications for health. J Nutr 134(3):489–492

    CAS  PubMed  Google Scholar 

  25. Altindag O, Celik H (2006) Total antioxidant capacity and the severity of the pain in patients with fibromyalgia. Redox Rep 11:131–135. doi:10.1179/135100006X116628

    Article  CAS  PubMed  Google Scholar 

  26. Cipollone JVF, Falasca K, Mezzetti A, Pizzigallo E, Bucciarelli T, Laurentis SD, Affaitati G, Cesare DD, Giamberardino AD (2003) Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett 335:151–154. doi:10.1016/S0304-3940(02)01058-3

    Article  PubMed  Google Scholar 

  27. Richard EH, Kahn K (2007) Current advances in understanding the pathophysiology of Fibromyalgia. American college of Rheumatology. 71st annual meeting

  28. Manuel YKB, Moorkens G, Vertommen J, Noé M, Neve J, De Leeuw I (2000) Magnesium status and parameters of the oxidant–antioxidant balance in patients with chronic fatigue: effects of supplementation with magnesium. J Am Coll Nutr 19:374–382

    Google Scholar 

  29. Ozgocmen S, Sogut S, Ardicoglu O, Fadillioglu E, Pekkutucu I, Akyol O (2004) Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 24:80–83. doi:10.1007/s00296-003-0335-y

    Article  CAS  PubMed  Google Scholar 

  30. Jackson MJ, O’Farrell S (1993) Free radicals and muscle damage. Br Med Bull 49(3):630–641

    CAS  PubMed  Google Scholar 

  31. Okumus M, Gokoglu F, Kocaoglu S, Ceceli E, Yorgancioglu ZR (2006) Muscle performance in patients with fibromyalgia. Singapore Med J 47:752–756

    CAS  PubMed  Google Scholar 

  32. Buchwald D, Garrity D (1994) Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 26:2049–2053. doi:10.1001/archinte.154.18.2049

    Article  Google Scholar 

  33. Singh A, Naidu PS, Gupta S, Kulkarni SK (2002) Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J Med Food 5(4):211–220. doi:10.1089/109662002763003366

    Article  CAS  PubMed  Google Scholar 

  34. Zaidi SM, Al-Qirim TM, Banu N (2005) Effects of antioxidant vitamins on glutathione depletion and lipid peroxidation induced by restraint stress in the rat liver. Drugs R D 6(3):157–165. doi:10.2165/00126839-200506030-00004

    Article  CAS  PubMed  Google Scholar 

  35. Vijayaraghavan R, Suribabu CS, Sekar B, Oommen PK, Kavithalakshmi SN, Madhusudhanan N, Panneerselvam C (2005) Protective role of vitamin E on the oxidative stress in Hansen’s disease (Leprosy) patients. Eur J Clin Nutr 59(10):1121–1128. doi:10.1038/sj.ejcn.1602221

    Article  CAS  PubMed  Google Scholar 

  36. Cao G, Booth SL, Sadowski JA, Prior RL (1998) Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. Am J Clin Nutr 68:1081–1087

    CAS  PubMed  Google Scholar 

  37. Merchant RE, Carmack CA, Wise CM (2000) Nutritional supplementation with Chlorella pyrenoidosa for patients with fibromyalgia syndrome: a pilot study. Phytother Res 14:167–173. doi:10.1002/(SICI)1099-1573(200005)14:3<167:AID-PTR560>3.0.CO;2-R

    Article  CAS  PubMed  Google Scholar 

  38. Deshpande RA, Adhikary P, Tipnis H (1974) Stored grain pest control agent from Nigella sativa and pogostemon heyneanus. Bull Grain Tech 12:232–234

    CAS  Google Scholar 

  39. Nair SC, Salomi MJ, Panikkar B, Panikkar KR (1991) Modulatory effects of Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in mice. Jethenopharm col 31:75–83

    CAS  Google Scholar 

  40. Badary OA, Taha RA, Gamel El Din AM, Abdel Wahab MH (2002) The in vitro antioxidant and pro-oxidant action of thymoquinone and tert butylhydroquinone. Egypt J Biochem Mol Biol 20:1–16

    Google Scholar 

  41. Riaz M, Syed M, Chaudhary FM (1996) Chemistry of the medicinal plants of the genus Nigella. Hamdard Med 39:40–45

    Google Scholar 

  42. Hanafy MSM, Hatem ME (1991) Studies on the antimicrobial activity of Nigella sativa seed. J Ethnopharmacol 34:275–278. doi:10.1016/0378-8741(91)90047-H

    Article  CAS  PubMed  Google Scholar 

  43. Burits M, Bucar F (2000) Antioxidant activity of Nigella sativa essential oil. Phytother Res 14:323–328. doi:10.1002/1099-1573(200008)14:5<323:AID-PTR621>3.0.CO;2-Q

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was financially supported by a grant from Higher Education Commission (H. E. C.), Islamabad, Pakistan.

Conflict of interest statement

The authors do not have any financial conflict.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Muhammad Arshad.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iqbal, R., Mughal, M.S., Arshad, N. et al. Pathophysiology and antioxidant status of patients with fibromyalgia. Rheumatol Int 31, 149–152 (2011). https://doi.org/10.1007/s00296-010-1470-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-010-1470-x

Keywords

Navigation